Analyst Research: Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

64.04USD
3:08pm EST
Change (% chg)

$1.90 (+3.06%)
Prev Close
$62.14
Open
$61.80
Day's High
$65.01
Day's Low
$61.00
Volume
56,715
Avg. Vol
96,509
52-wk High
$70.80
52-wk Low
$12.75

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
ValuEngine Industry Report for Medical-drugs(ESPR) 2 Mar 2015 ValuEngine, Inc. 10 49.00
ValuEngine Rating and Forecast Report for ESPR 1 Mar 2015 ValuEngine, Inc. 11 25.00
Esperion Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 27 Feb 2015 Reuters Investment Profile 12 20.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 20 Feb 2015 Zacks Investment Research Inc. 1 12.00
Value Graph: ESPERION THERAPE -- ESPR 19 Feb 2015 Ford Investor Services, Inc. 1 12.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 19 Feb 2015 Zacks Investment Research Inc. 1 12.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 18 Feb 2015 Zacks Investment Research Inc. 1 12.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 16 Feb 2015 Zacks Investment Research Inc. 1 12.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 13 Feb 2015 Zacks Investment Research Inc. 1 12.00
ESPERION THERAP (ESPR) Zacks Company Snapshot 12 Feb 2015 Zacks Investment Research Inc. 1 12.00
 
Name Age Since Current Position

Roger Newton

63 Executive Chairman of the Board, Chief Scientific Officer

Timothy Mayleben

53 2004 President, Chief Executive Officer

Narendra Lalwani

61 2014 Chief Operating Officer, Executive Vice President - Research & Development

Antonio Gotto

78 2014 Director

Mark McGovern

61 2014 Director
Search Stocks